EE338 The Potential Benefit of Respiratory Syncytial Virus (RSV) Vaccination in Older Adults: A Comparison of the United States (US) and United Kingdom (UK)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.584
https://www.valueinhealthjournal.com/article/S1098-3015(22)02788-7/fulltext
Title :
EE338 The Potential Benefit of Respiratory Syncytial Virus (RSV) Vaccination in Older Adults: A Comparison of the United States (US) and United Kingdom (UK)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02788-7&doi=10.1016/j.jval.2022.09.584
First page :
Section Title :
Open access? :
No
Section Order :
10121